ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma (vol 4, pg 2540, 2022)Marina Georgiou,Panagiota Ntavelou,William Stokes,Rajat Roy,Geoffrey J. Maher, Tsvetana Stoilova,Josephine A. M. Y. Choo,Callum P. Rakhit,Miguel Martins, Paul Ajuh,Neil Horowitz,Ross S. Berkowitz,Kevin Elias,Michael J. Seckl,Olivier E. PardoONCOGENE(2022)引用 3|浏览8暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要